CRSP
Price
$45.49
Change
-$0.57 (-1.24%)
Updated
Sep 22, 6:59 PM EST
37 days until earnings call
LIAN
Price
$1.54
Change
+$0.04 (+2.67%)
Updated
Sep 25, 9:02 AM EST
73 days until earnings call

Analysis and predictions CRSP vs LIAN

Header iconCRSP vs LIAN Comparison
Open Charts CRSP vs LIANBanner chart's image
CRISPR Therapeutics AG
Price$45.49
Change-$0.57 (-1.24%)
Volume$330.85K
CapitalizationN/A
LianBio
Price$1.54
Change+$0.04 (+2.67%)
Volume$1.7K
CapitalizationN/A
View a ticker or compare two or three
CRSP vs LIAN Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
CRSP vs. LIAN commentary
Sep 25, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and LIAN is a Hold.

COMPARISON
Comparison
Sep 25, 2023
Stock price -- (CRSP: $45.49 vs. LIAN: $1.50)
Brand notoriety: CRSP and LIAN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 68% vs. LIAN: 24%
Market capitalization -- CRSP: $3.61B vs. LIAN: $160.75M
CRSP [@Biotechnology] is valued at $3.61B. LIAN’s [@Biotechnology] market capitalization is $160.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileLIAN’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • LIAN’s FA Score: 1 green, 4 red.
According to our system of comparison, LIAN is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while LIAN’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 4 bearish.
  • LIAN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than LIAN.

Price Growth

CRSP (@Biotechnology) experienced а -10.06% price change this week, while LIAN (@Biotechnology) price change was -6.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.79%. For the same industry, the average monthly price growth was +32.38%, and the average quarterly price growth was +31.88%.

Reported Earning Dates

CRSP is expected to report earnings on Nov 01, 2023.

LIAN is expected to report earnings on Dec 07, 2023.

Industries' Descriptions

@Biotechnology (-4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRSP with price predictions.
OPEN
A.I.dvisor published
a Summary for LIAN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRSP($3.61B) has a higher market cap than LIAN($161M). CRSP has higher P/E ratio than LIAN: CRSP (20.92) vs LIAN (1.55). CRSP YTD gains are higher at: 11.907 vs. LIAN (-8.537). LIAN has higher annual earnings (EBITDA): -103.55M vs. CRSP (-452.76M). CRSP has more cash in the bank: 1.77B vs. LIAN (267M). LIAN has less debt than CRSP: LIAN (3.3M) vs CRSP (245M). CRSP has higher revenues than LIAN: CRSP (170M) vs LIAN (0).
CRSPLIANCRSP / LIAN
Capitalization3.61B161M2,243%
EBITDA-452.76M-103.55M437%
Gain YTD11.907-8.537-139%
P/E Ratio20.921.551,348%
Revenue170M0-
Total Cash1.77B267M662%
Total Debt245M3.3M7,424%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPLIAN
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBDO25.33N/A
N/A
iShares iBonds Dec 2023 Term Corp ETF
WCEO24.81-0.06
-0.25%
Hypatia Women CEO ETF
TEQI33.87-0.17
-0.49%
T. Rowe Price Equity Income ETF
IAI92.58-0.56
-0.60%
iShares US Broker-Dealers&Secs Exchs ETF
EUM15.10-0.16
-1.08%
ProShares Short MSCI Emerging Markets

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.24%
BEAM - CRSP
75%
Closely correlated
-4.81%
NTLA - CRSP
73%
Closely correlated
-3.40%
EDIT - CRSP
68%
Closely correlated
-1.88%
SANA - CRSP
63%
Loosely correlated
-3.28%
VERV - CRSP
62%
Loosely correlated
-2.89%
More

LIAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIAN has been loosely correlated with FATE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if LIAN jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIAN
1D Price
Change %
LIAN100%
N/A
FATE - LIAN
47%
Loosely correlated
-3.65%
SRNEQ - LIAN
34%
Loosely correlated
-2.54%
AXON - LIAN
34%
Loosely correlated
-0.36%
ZLAB - LIAN
33%
Poorly correlated
+2.04%
QNCX - LIAN
32%
Poorly correlated
-1.71%
More